Veradermics Statistics
NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
119.52-4.87 (-3.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Veradermics by the numbers
Veradermics has a market capitalization of $5.04 billion based on 42.20M shares outstanding. With trailing EPS of $-3.89, Veradermics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.2% below its 50-day average and 22.7% above its 200-day average.
Average daily trading volume is 738.22K shares, or about $88.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MANE valuation vs. peer median
| Metric | MANE | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.04B | $4.77B | +6% |
| Avg. volume | 738.22K | 1.44M | -49% |
Peer median across 8 companies: BLTE, LQDA, ERAS, DNTH, PTCT, COGT, GRFS, TVTX.
Valuation
- Market cap
- $5.04B
- EPS (TTM)
- $-3.89
- Shares outstanding
- 42.20M
Price and trading
- Previous close
- 124.39
- Open
- 121.98
- Day range
- 118.99 – 123.70
- 52-week range
- 32.00 – 156.63
- 50-day moving average
- 124.70
- Beta
- —
- Volume
- 374.92K
- Average volume
- 738.22K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 5.04B
- Forward Pe
- -46.31
- Eps
- -3.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 156.63
- Week52 Low
- 32.00
- Avg Volume
- 738.22K
- Shares Outstanding
- 42.20M
- Ma50
- 124.70
- Ma200
- 97.38
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -23.69%
- Pct From52w Low
- 273.50%